The dark side of granulocyte-colony stimulating factor: a supportive therapy with potential to promote tumour progression
Belinda Yeo, Andrew D Redfern, Kellie A Mouchemore, John A Hamilton, Robin L Anderson
Clinical & Experimental Metastasis | SPRINGER | Published : 2018
Awarded by National Health and Medical Research Council (NHMRC)
Awarded by National Breast Cancer Foundation (NBCF) of Australia
The authors wish to acknowledge grant support from the National Health and Medical Research Council (NHMRC) (APP1080560 - RLA and JAH) and from the National Breast Cancer Foundation (NBCF) of Australia (PS-15-022 - RLA and JAH). Fellowship support from the NBCF (RLA) and scholarship support from Monash University (KAM) are also acknowledged. Olivia Newton-John Cancer Research Institute acknowledges the support of Operational Infrastructure Program of Victorian Government.